Moreover, no significant associations were found between MEF2A and SLC22A3-LPAL2-LPA haplotypes and cardiovascular disease among patients and healthy controls (P ˃ 0.05) (S4 Table in S1 File). This evidence concerns the gene SLC22A3 and cardiovascular disorder.